Skip to content
Log in

Dual-granularity feature learning reveals static and dynamic mechanisms of ncRNA-drug interactions.

Runzhou Tang Xi Zhou Yujie Qi Xiaobo Zhu Yu-an Huang Lun Hu Zhuhong You Pengwei Hu
Jul 2026 · IEEE journal of biomedical and health informatics · Vol PP, pp. 1-14 · 0 citations
Medicine

TL;DR

DC-MetaMG, a deep learning framework based on a causal disentanglement strategy that models association responses as the synergistic interplay between two complementary mechanisms: static binding and dynamic regulation, is proposed, demonstrating its suitability for training scenarios involving complex biological information.

Abstract

Accurately identifying interactions between non-coding RNAs (ncRNAs) and drugs is crucial for elucidating drug mechanisms and advancing drug repositioning. Existing deep learning-based methods for ncRNA-drug association prediction typically leverage multi-source biological information to learn informative representations, thereby alleviating the cold-start issue arising from the scarcity of experimentally validated associations. However, the direct fusion of multi-source features often introduces feature redundancy, semantic conflicts, and high-dimensional feature sparsity, thereby hindering model convergence and degrading predictive performance. To address these challenges, this study proposes DC-MetaMG, a deep learning framework based on a causal disentanglement strategy that models association responses as the synergistic interplay between two complementary mechanisms: static binding and dynamic regulation. By characterizing the principal patterns underlying differential responses between drugs and ncRNAs across multiple dimensions, the proposed framework effectively suppresses spurious associations arising from irrelevant feature interactions and mitigates the adverse effects introduced during model training with multi-source biomedical information, thereby improving the reliability of association prediction. Experiments conducted on lncRNA-drug and miRNA-drug datasets demonstrate the superior performance of the proposed model. Under five-fold cross-validation, the proposed model achieves an average AUC improvement of 0.41% over competing methods. Under the cold evaluation experiments, the AUC, ACC, and AUPR metrics show average increases of 1.22%, 0.51%, and 0.35%, respectively. Case studies further demonstrate the interpretability of the model. Furthermore, visualization analyses confirm the effective characterization of the two underlying association mechanisms, highlighting the model's ability to disentangle and integrate multi-source biological information, thereby demonstrating its suitability for training scenarios involving complex biological information.

DOI PubMed Semantic Scholar
View source

Similar papers

Jul 2026

Higher-Order Dynamic Disentangled Intent Sensing and Bidirectional Joint Updating Framework for NcRNA-Drug Resistance Association Prediction.

Noncoding RNAs (ncRNAs) are critical regulators of drug response and disease progression, making accurate prediction of ncRNA-drug resistance associations a key task in pharmacogenomics and precision medicine. However, current methods largely rely on global neighborhood aggregation, which treats node contexts as homogeneous and overlooks fine-grained structural and semantic heterogeneity. Moreover, they often model ncRNAs and drugs as interchangeable nodes, disregarding their biological distinctions and asymmetric interactions, and failing to effectively integrate modality-specific and cross-modal features. To overcome these limitations, we propose HDBI, a higher-order dynamic disentangled framework for predicting ncRNA-drug resistance associations. HDBI integrates multiview hypergraph learning, disentangled representation modeling, and bidirectional cross-modal updating to capture heterogeneous topological and semantic patterns within ncRNA and drug spaces while preserving modality-specific characteristics and enabling cross-modal information exchange. Extensive experiments on two benchmark data sets demonstrate that HDBI consistently outperforms state-of-the-art methods. Case studies on 5-FU and Docetaxel further support the biological relevance of the predictions, with 22/30 and 21/30 top-ranked ncRNAs supported by PubMed evidence, respectively. Functional enrichment and molecular docking analyses further linked these predictions to drug-relevant pathways and structurally plausible regulatory interactions. These findings suggest that HDBI provides an effective and interpretable framework for prioritizing ncRNA-mediated drug resistance associations and guiding downstream mechanistic investigation.

Tiyao Liu, Shudong Wang, Baoming Feng et al. · 0 citations
Aug 2026

LOGIC: LLM-Driven Cross-Scale Feature Coupling for Drug-Disease Interaction Prediction.

The key innovation of LOGIC lies in constructing a dictionary of functional groups and symptoms, and performing a simple and intuitive multi-hot encoding of drugs and diseases at the micro-scale, and in employing large language models (LLMs) to derive the meso-scale features of diseases without requiring additional domain knowledge.

Yunfei He, Shikai Chen, Yuchen Zhao et al. · 0 citations
Aug 2026

MKASynergy: an adaptive method for drug synergy prediction via a mixture-of-experts kernel mechanism

MKASynergy, an adaptive drug synergy prediction method based on a mixture-of-experts kernel mechanism, achieves competitive predictive performance and visualization analysis confirms the model’s effectiveness in feature decoupling and helps interpret latent drug synergistic mechanisms.

Cundong Lin, Jiancheng Ni, Ying Yang et al. · 0 citations